Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation (original) (raw)
Cavert, W. et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science276, 960–964 (1997). ArticleCAS Google Scholar
Lafeuillade, A., Poggi, C., Profizi, N., Tamalet, C. . & Costes, O. Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. J. Infect. Dis.174, 404–407 (1996). ArticleCAS Google Scholar
Perelson, A.S. et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature387, 188–191 (1997). ArticleCAS Google Scholar
Notermans, D.W. et al. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. AIDS (in the press).
Wei, X. et al. Viral dynamics in human immunodeficiency virus typei infection. Nature373, 117–122 (1995). ArticleCAS Google Scholar
Ho, D.D. et al. lymphocytes in HIV-1 infection. Nature373, 123–126 (1995). ArticleCAS Google Scholar
Kelleher, A.D., Carr, A., Zaunders, J. & Cooper, D.A. Alterations in the immune response of human immunodeficiency virus (HIV) infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis.173, 321–329 (1996). ArticleCAS Google Scholar
Picker, L.J. et al. Control of lymphocyte recirculation in man: Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J.Immunol.150 1105–1121 (1993) CASPubMed Google Scholar
Roederer, M. et al. CD8 naive T cell counts decrease progressively in HIV infected adults. J. Clin. Invest95, 2061–2066 (1995). ArticleCAS Google Scholar
Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science271, 1582–1586 (1996). ArticleCAS Google Scholar
Tough, D.F. & Sprent, J. Viruses and T cell turnover: Evidence for bystander proliferation. Immunol. Rev.150,129–142 (1996). ArticleCAS Google Scholar
Ahmed, R. & Gray, D. Immunological memory and protective immunity: Understanding their relation. Science272,54–60 (1996). ArticleCAS Google Scholar
Mosier, D.E., Sprent, J., Tough, D., Dimitrov, D.S. & Martin, M.A. HIV results in the frame: CD4+ cell turnover (letter). Nature375, 193–195 (1995). ArticleCAS Google Scholar
Phillips, A.N., Sabin, C.A., Mocroft, A. & janossy, C. HIV results in the frame: Antiviral therapy (letter). Nature375, 195 (1995). ArticleCAS Google Scholar
Westermann, J. & Pabst, R. Lymphocyte subsets in the blood: A diagnostic window on the lymphoid system? Immunol. Today11, 406 (1990). ArticleCAS Google Scholar
Butcher, E.C. & Picker, L.J. Lymphocyte homing and homeostasis. Science272, 60–66(1996). ArticleCAS Google Scholar
Pantaleo, G. et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature362, 355–358 (1993). ArticleCAS Google Scholar
Giorgi, J.V. Phenotype and function of T cells in HIV disease, in Immunology of HIV Infection. (ed. Gupta, S.) 181–199 (Plenum Press, New York, 1996). Book Google Scholar
Wang, L., Robb, C.W. & Cloyd, M.W. HIV induces homing of resting T lymphocytes to lymph nodes.Virology228, 141–152 (1997). ArticleCAS Google Scholar
Zhang, Z. et al. Naive CD4+ T cells repopulate lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci USA (in the press).
Connors, M. et al. Infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med.3, 533–540 (1997). ArticleCAS Google Scholar
Wolthers, K.C. et al. T-cell telomore length infection: No evidence for increased CD4+ T cell turnover. Science274, 1543–1547 (1996). ArticleCAS Google Scholar
Pommier, J.-P. et al. Immunosenescence in HIV pathogenesis. Virology231, 148–154(1997). ArticleCAS Google Scholar
Palmer, L.D. et al. Telomere length, telomerase activity, and replicative potential in HIV infection: Analysis of CD4+ and CD8+ T cells from HIV-discordant monozy-gotic twins. J. Exp. Med.185, 1381–1386 (1997). ArticleCAS Google Scholar
Paganin, C., Monos, D.S., Marshall, J.D., Frank, I., & Trinchieri, G. Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: Implications for T cell proliferation in HIV disease J. Clin. Invest.99, 663–667 (1997). ArticleCAS Google Scholar
Mackall, C.L. et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med.332, 143–149 (1995). ArticleCAS Google Scholar
Ottinger, H.D., Beelen, D.W., Scheulen, B., Schaefer, U.W. & Gross-Wilde, H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood88, 2775–2779 (1996). CASPubMed Google Scholar
Rep, M. et al. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-τ secreting TH1 cells in humans. J. Clin. Invest.99, 2225–2231 (1997). ArticleCAS Google Scholar
Weng, N.-P., Levine, B.L., June, C.H. & Hodes, R.J. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA92,11091–11094 (1995). ArticleCAS Google Scholar
Autran, B. et al. 4+ T cell homeostasis and function in advanced HIV disease. Science277 112–116 (1997). ArticleCAS Google Scholar
Hammer, S.M. et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N. Engl. J. Med.335,1081 1090 (1996). ArticleCAS Google Scholar
Katzenstein, D.A. et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N. Engl. J. Med.335, 1091–1098 (1996). ArticleCAS Google Scholar
Delta coordinating committee. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet348, 283–291 (1996).
O'Brien, W.A. et al. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann. Intern. Med.126, 939–945 (1997). ArticleCAS Google Scholar
Roos, M.T.L. et al. T-cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus (HIV)-infected asymptomatic individuals. J. Infect. Dis.171, 531–536 (1995). ArticleCAS Google Scholar
Koot, M. et al. Viral phenotype and T-cell reactivity in human immunodeficiency virus type 1 -infected asymptomatic men treated with zidovudine. J. Infect. Dis.168,733–736(1993). ArticleCAS Google Scholar
Bindels, P.J.E. et al. The predictive value of T cell function in vitro and pre AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam. J. Infect. Dis.172, 97–104 (1995). ArticleCAS Google Scholar
Pakker, N.G. et al. Patterns of T cell repopulation, viral load reduction and restoration of T cell function in human immunodeficiency virus infected persons during therapy with different antiretrovirals. J. Acquire. Immune Defic. Syndr. Hum. Retrovirol.16, 318–326 (1997). ArticleCAS Google Scholar
Bloemena, E., Roos, M.T.L., van Heijst, J.L.A.M., Vossen, J.M.J.j. & Schellekens, P.T.A. Whole-blood lymphocyte cultures. J. Immunol. Methods122, 161–167 (1989). ArticleCAS Google Scholar
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid. Mortal. Wkly. Rep.41, 1 (1992).